Antiangiogenic properties of Koetjapic acid, a natural triterpene isolated from Sandoricum koetjaoe Merr

Cancer Cell International

Volumn 11, Issue , 2011, Pages

  Nassar, Zeyad D ^a   Aisha, Abdalrahim F A ^a   Ahamed, Mohamed B K ^a   Ismail, Zhari ^a   Abu Salah, Khalid M ^b   Alrokayan, Salman A ^b   Abdul Majid, Amin M S ^a,c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KOETJAPIC ACID; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFECT; ENDOTHELIUM CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; IC 50; MALE; MEDICINAL PLANT; MICROVASCULATURE; NONHUMAN; PROTEIN EXPRESSION; RAT; SANDORICUM KOETJAOE;

EID: 79955132556     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-11-12     Document Type: Article

References (36)

1. DeWitt N. Angiogenesis. Nature 2005, 438(7070):931-931.
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438(7070):932-936. 10.1038/nature04478, 16355210.
3. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987, 235(4787):442-447. 10.1126/science.2432664, 2432664.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1(1):27-30. 10.1038/nm0195-27, 7584949.
5. Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976, 16:207-248.
6. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991, 324(1):1-8. 10.1056/NEJM199101033240101, 1701519.
7. Kaneda N, Pezzuto J, Kinghorn A, Farnsworth N, Santisuk T, Tuchinda P, Udchachon J, Reutrakul V. Plant anticancer agents, L. cytotoxic triterpenes from Sandoricum koetjape stems. J Nat Prod 1992, 55(5):654-659. 10.1021/np50083a016, 1517737.
8. Aisha AFA, Sahib H, Abu-Salah K, Darwis Y, Abdul Majid A. Cytotoxic and Anti-Angiogenic Properties of the Stem Bark Extract of Sandoricum koetjape. Int J Cancer Res 2009, 5:105-114.
9. Ismail IS, Ito H, Mukainaka T, Higashihara H, Enjo F, Tokuda H, Nishino H, Yoshida T. Ichthyotoxic and anticarcinogenic effects of triterpenoids from Sandoricum koetjape bark. Biol Pharm Bull 2003, 26(9):1351-1353. 10.1248/bpb.26.1351, 12951486.
10. West DC, Burbridge MF. Three-dimensional in vitro anglogenesis in the rat aortic ring model. Methods Mol Biol 2009, 467:189-210. 10.1007/978-1-59745-241-0_11, 19301672.
11. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3(6):401-410. 10.1038/nrc1093, 12778130.
12. Folkman J. Role of angiogenesis in tumor growth and metastasis. Seminars in Oncology 2002, 29(6, Supplement 16):15-18.
13. Aisha AFA, Abu-Salah K, Darwis Y, Abdul Majid A. Screening of Antiangiogenic Activity of Some Tropical Plants by Rat Aorta Ring Assay. international Journal of Cancer 2009, 5(6):370-376.
14. Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, Dai R, Hu Z. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sciences 2004, 74(20):2467-2478. 10.1016/j.lfs.2003.03.005, 15010258.
15. Sun DA, Starck SR, Locke EP, Hecht SM. DNA polymerase beta inhibitors from Sandoricum koetjape. J Nat Prod 1999, 62(8):1110-1113. 10.1021/np990104r, 10479314.
16. Muhammad I, El Sayed KA, Mossa JS, Al-Said MS, El-Feraly FS, Clark AM, Hufford CD, Oh S, Mayer AMS. Bioactive 12-Oleanene Triterpene and Secotriterpene Acids from Maytenus undata. Journal of Natural Products 2000, 63(5):605-610. 10.1021/np990456y, 10843569.
17. Rasadah MA, Khozirah S, Aznie AA, Nik MM. Anti-inflammatory agents from Sandoricum koetjape Merr. Phytomedicine 2004, 11(2-3):261-263. 10.1078/0944-7113-00339, 15070182.
18. Nassar ZD, Aisha AFA, Majid AMSA, Yeap CS, Fun HK. Koetjapic acid chloroform hemisolvate. Acta Crystallographica Section E 2010, 66(6):o1301-o1302.
19. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002, 2(10):795-803. 10.1038/nrc909, 12360282.
20. Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997, 80(1):98-106. 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A, 9210714.
21. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327(6122):524-526. 10.1038/327524a0, 3495737.
22. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83(5):1774-1777. 10.1172/JCI114081, 303890, 2540223.
23. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992, 90(3):1168-1172. 10.1172/JCI115937, 329981, 1522225.
24. Janicek MJ, Meyerovitz M, Harrington DP, Hollenberg NK. Arterial response to ketanserin and aspirin in patients with advanced peripheral atherosclerosis. Invest Radiol 1992, 27(6):415-421. 10.1097/00004424-199206000-00003, 1607256.
25. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. American Journal of Physiology - Heart and Circulatory Physiology 1993, 265(2):H586-H592.
26. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM. Vascular Endothelial Growth Factor/Vascular Permeability Factor Augments Nitric Oxide Release From Quiescent Rabbit and Human Vascular Endothelium. Circulation 1997, 95(4):1030-1037.
27. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM. Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin. Circulation 1998, 97(1):99-107.
28. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996, 270(1 Pt 2):H411-415.
29. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN. Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 2006, 27(6):297-309. 10.1016/j.tips.2006.04.006, 16697473.
30. Yang S, Xin X, Zlot C, Ingle G, Fuh G, Li B, Moffat B, de Vos AM, Gerritsen ME. Vascular Endothelial Cell Growth Factor-Driven Endothelial Tube Formation Is Mediated by Vascular Endothelial Cell Growth Factor Receptor-2, a Kinase Insert Domain-Containing Receptor. Arterioscler Thromb Vasc Biol 2001, 21(12):1934-1940. 10.1161/hq1201.099432, 11742867.
31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65(1-2):55-63. 10.1016/0022-1759(83)90303-4, 6606682.
32. Brown KJ, Maynes SF, Bezos A, Maguire DJ, Ford MD, Parish CR. A novel in vitro assay for human angiogenesis. Lab Invest 1996, 75(4):539-555.
33. Nicosia RF, Lin YJ, Hazelton D, Qian X. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am J Pathol 1997, 151(5):1379-1386. 1858079, 9358764.
34. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protocols 2007, 2(2):329-333.
35. Bsndyopadhyay A, Zhu Y, Malik SN, Kreisberg J, Brattain MG, Sprague EA, Luo J, L'opez-Casillas F, Sun LZ. Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells. Oncogene 2002, 21:3541-3551. 10.1038/sj.onc.1205439, 12032856.
36. West DC, Thompson WD, Sells PG, Burbridge MF. Angiogenesis Assays Using Chick Chorioallantoic Membrane. Angiogenesis Protocols 2001, 46:2001. Totowa, NJ: Humana Press Inc, Murray JC.